Abbott Launches Clinical Trial of Innovative Lithotripsy Device for Coronary Artery Disease Patients Abbott has received FDA approval for a clinical trial assessing its Intravascular Lithotripsy device aimed at treating coronary artery disease. This new technology could enhance patient outcomes significantly.

Abbott Launches Clinical Trial of Innovative Lithotripsy Device for Coronary Artery Disease Patients #United_States #Abbott #Abbott_Park #CAD #Intravascular_Lithotripsy